Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2016 Feb 3

PMID 26831489

Citations 13

Authors

Donna M Evon

Abdus S Wahed

Geoffrey Johnson

Mandana Khalili

Mauricio Lisker-Melman

Robert J Fontana

Souvik Sarkar

Bryce B Reeve

Jay H Hoofnagle

Affiliations

Soon will be listed here.

Abstract

Background: Fatigue is a common symptom of liver disease but not well characterized in patients with chronic hepatitis B virus (HBV).

Aims: We assessed the rate of fatigue using a validated instrument in patients with HBV and identified demographic, virologic, and clinical features associated with fatigue in a cross-sectional cohort study from the Hepatitis B Research Network.

Methods: Participants were English- and Spanish-speaking adults with chronic HBV who were not pregnant nor on treatment. Fatigue was measured using the PROMIS® Fatigue 7-item Short Form.

Results: The sample included 948 adults: median age 42; 51 % female; 71 % Asian; 74 % college educated; 77 % employed; 41 % inactive HBV carriers; 36 % with active chronic disease; and 2 % with advanced fibrosis, defined as AST-platelet ratio index (APRI) > 1.50. Patients with chronic HBV had a mean fatigue T-score of 46.8 ± SD = 7.9, compared to a mean fatigue T-score of 50.0 ± 10 in the US general population (p < .0001). In univariate analyses, greater fatigue was associated with demographic and clinical features such as female sex, lower income, more comorbidities, higher APRI score, and poorer mental health (p < 0.05). In multivariate analysis, female sex (p < .001), poorer mental health (p < .001), APRI score (p = .005), and history of diabetes (p = .039) were the strongest independent predictors.

Conclusions: The frequency of fatigue in this large cohort of North American chronic HBV patients may be equal to or lower than that reported in the US general population. Patients with advanced fibrosis, more comorbidities, and poorer mental health report worse fatigue.

Citing Articles

Direct-Acting Antiviral Drugs Reduce Fibromyalgia Symptoms in Patients with Chronic Hepatitis C.

Tang K, Lin C, Chen Y, Liao T, Chen D, Yang S J Clin Med. 2022; 11(18).

PMID: 36142974 PMC: 9500682. DOI: 10.3390/jcm11185327.

The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy.

Abe K, Fujita M, Hayashi M, Takahashi A, Ohira H Intern Med. 2021; 60(22):3533-3542.

PMID: 34776465 PMC: 8666222. DOI: 10.2169/internalmedicine.7175-21.

Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B.

Evon D, Lin H, Fontana R, Khalili M, Yim C, Wahed A GastroHep. 2021; 3(3):196-208.

PMID: 34421369 PMC: 8372034. DOI: 10.1002/ygh2.458.

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.

Buti M, Stepanova M, Palom A, Riveiro-Barciela M, Nader F, Roade L JHEP Rep. 2021; 3(3):100280.

PMID: 34041466 PMC: 8141931. DOI: 10.1016/j.jhepr.2021.100280.

A scoping review to identify and map the multidimensional domains of pain in adults with advanced liver disease.

Gorospe F, Istanboulian L, Puts M, Wong D, Lee E, Dale C Can J Pain. 2021; 4(1):210-224.

PMID: 33987500 PMC: 7951148. DOI: 10.1080/24740527.2020.1785855.

References

Dwight M, Kowdley K, Russo J, Ciechanowski P, Larson A, Katon W . Depression, fatigue, and functional disability in patients with chronic hepatitis C. J Psychosom Res. 2001; 49(5):311-7. DOI: 10.1016/s0022-3999(00)00155-0. View

Younossi Z, Boparai N, Price L, Kiwi M, McCormick M, Guyatt G . Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol. 2001; 96(7):2199-205. DOI: 10.1111/j.1572-0241.2001.03956.x. View

Poynard T, Cacoub P, Ratziu V, Myers R, Dezailles M, Mercadier A . Fatigue in patients with chronic hepatitis C. J Viral Hepat. 2002; 9(4):295-303. DOI: 10.1046/j.1365-2893.2002.00364.x. View

Pojoga C, Dumitrascu D, Pascu O, Grigorescu M, Radu C, Damian D . Impaired health-related quality of life in Romanian patients with chronic viral hepatitis before antiviral therapy. Eur J Gastroenterol Hepatol. 2004; 16(1):27-31. DOI: 10.1097/00042737-200401000-00005. View

Pawlikowska T, Chalder T, Hirsch S, Wallace P, Wright D, Wessely S . Population based study of fatigue and psychological distress. BMJ. 1994; 308(6931):763-6. PMC: 2539651. DOI: 10.1136/bmj.308.6931.763. View

Wilson I, Cleary P . Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995; 273(1):59-65. View

Foster G, Goldin R, Thomas H . Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998; 27(1):209-12. DOI: 10.1002/hep.510270132. View

Lang C, Conrad S, Garrett L, Battistutta D, Cooksley W, Dunne M . Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. J Pain Symptom Manage. 2006; 31(4):335-44. DOI: 10.1016/j.jpainsymman.2005.08.016. View

Ricci J, Chee E, Lorandeau A, Berger J . Fatigue in the U.S. workforce: prevalence and implications for lost productive work time. J Occup Environ Med. 2007; 49(1):1-10. DOI: 10.1097/01.jom.0000249782.60321.2a. View

10.

Ozkan M, Corapcioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S . Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med. 2007; 36(3):283-97. DOI: 10.2190/D37Y-X0JY-39MJ-PVXQ. View

11.

Younossi Z, Kallman J, Kincaid J . The effects of HCV infection and management on health-related quality of life. Hepatology. 2007; 45(3):806-16. DOI: 10.1002/hep.21565. View

12.

DeWalt D, Rothrock N, Yount S, Stone A . Evaluation of item candidates: the PROMIS qualitative item review. Med Care. 2007; 45(5 Suppl 1):S12-21. PMC: 2810630. DOI: 10.1097/01.mlr.0000254567.79743.e2. View

13.

Reeve B, Hays R, Bjorner J, Cook K, Crane P, Teresi J . Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007; 45(5 Suppl 1):S22-31. DOI: 10.1097/01.mlr.0000250483.85507.04. View

14.

Bao Z, Qiu D, Ma X, Fan Z, Zhang G, Huang Y . Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol. 2007; 13(21):3003-8. PMC: 4171157. DOI: 10.3748/wjg.v13.i21.3003. View

15.

Buster E, Hansen B, Buti M, Delwaide J, Niederau C, Michielsen P . Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis. Hepatology. 2007; 46(2):388-94. DOI: 10.1002/hep.21723. View

16.

Kallman J, ONeil M, Larive B, Boparai N, Calabrese L, Younossi Z . Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007; 52(10):2531-9. DOI: 10.1007/s10620-006-9708-x. View

17.

Bondini S, Kallman J, Dan A, Younoszai Z, Ramsey L, Nader F . Health-related quality of life in patients with chronic hepatitis B. Liver Int. 2007; 27(8):1119-25. DOI: 10.1111/j.1478-3231.2007.01558.x. View

18.

Garcia S, Cella D, Clauser S, Flynn K, Lad T, Lai J . Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol. 2007; 25(32):5106-12. DOI: 10.1200/JCO.2007.12.2341. View

19.

Hann H, Han S, Block T, Harris M, Maa J, Fisher R . Symptomatology and health attitudes of chronic hepatitis B patients in the USA. J Viral Hepat. 2007; 15(1):42-51. PMC: 2229833. DOI: 10.1111/j.1365-2893.2007.00895.x. View

20.

Levy A, Kowdley K, Iloeje U, Tafesse E, Mukherjee J, Gish R . The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value Health. 2008; 11(3):527-38. DOI: 10.1111/j.1524-4733.2007.00297.x. View